ASC Ancillary · CPT/HCPCS
HCPCS Q0249
Tocilizumab for covid-19
HCPCS Q0249 at a glance
- Code
- Q0249
- Code type
- CPT/HCPCS
- Short descriptor
- Tocilizumab for covid-19
- Category
- ASC Ancillary
- ASC eligibility
- ASC-eligible (ancillary)
- Typical setting
- Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
What is HCPCS code Q0249?
HCPCS Q0249 is a CPT/HCPCS procedure code. Its official short descriptor is "Tocilizumab for covid-19". In the ASC context it is grouped under ASC Ancillary.
Is HCPCS Q0249 eligible in an ambulatory surgery center (ASC)?
HCPCS Q0249 is an ancillary service that can be provided in the ASC setting when it supports a surgical procedure.
Where is HCPCS Q0249 typically performed?
Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
Reference information about ASC eligibility and typical procedure setting. Codes, descriptors, and ASC-eligibility status change over time. This is a coding reference, not billing, coding, or legal advice. Always verify against current guidance and individual payer policy before scheduling or billing. CPT is a registered trademark of the American Medical Association.